Q1 2022 AddLife AB Earnings Call Transcript
()-&
My name is Kristina Willgard. I'm very happy to present to you the interim report. I think it's a very strong report for the first quarter. And if we look on the highlights for this quarter, we did right -- it was a successful quarter because still, I think we do a very good -- both sales growth but also a profit growth in this quarter. You see when you look into the report that the acquisitions are driving the sales in Medtech, which is actually exactly what we expected. You know that we have done a lot of acquisitions during the last 2 years within our MedTech business area. If we exclude the sales with COVID-19 products, we actually had an underlying organic growth of 5% in this quarter, which I think also is very strong. And both business areas actually had a positive growth, excluding COVID sales. We have completed 2 acquisitions in the quarter that was of MBA and Telia and another 2 was finalized after the quarter, and that was OâFlynn and BioCat.
So summarizing this quarter, we had
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |